相关实验视频
Updated: May 14, 2026

08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
由抗癌药物组合形成的超分子纳米结构
Andrew G Cheetham1, Pengcheng Zhang, Yi-an Lin
1Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland 21218, USA.
Journal of the American Chemical Society
|February 6, 2013
概括
研究人员开发了一种新的方法,可以从抗癌药物坎普托塞辛 (CPT) 中创建稳定的纳米结构. 这些自我递送的药物纳米结构提供受控释放,并显示对癌细胞的有效性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 像坎普托塞辛 (CPT) 这样的疏水性抗癌药物在配方和输送方面面临着挑战.
- 开发稳定,高负载的药物输送系统对于有效的癌症治疗至关重要.
研究的目的:
- 开发一种超分子策略,将坎普托素 (CPT) 组装成明确的纳米结构.
- 为了研究这些纳米结构的药物加载,稳定性和受控释放特性.
- 为了评估CPT纳米结构对癌症细胞系的体外疗效.
主要方法:
- 使用可生物降解的链接剂进行坎プト素 (CPT) 的超分子自我组装.
- 纳米结构形态 (纳米纤维,纳米管) 和药物载荷含量 (23-38%) 的表征.
- 在瘤相关条件下的体外药物释放研究和细胞毒性测定.
主要成果:
- 成功组装CPT成稳定的纳米纤维或纳米管,具有高的定量药物负载.
- 纳米结构的形成保护了CPT和链接器,使药物释放得到控制.
- CPT纳米结构在体外证明了对各种癌症细胞系的有效性.
结论:
- 这种超分子策略使得水抗癌药物可以直接组装成自传递纳米结构.
- 开发的纳米结构提供了增强的药物保护,可控释放和强大的抗癌活性.
- 这种方法可以扩展到其他抗癌药物,为癌症治疗提供了新的途径.
相关概念视频
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...

